Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Les Abymes

10 clinical trials in Les Abymes, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Les Abymes at a glance
10
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

10 trials in Les Abymes

Open in trial search

Study of lidocaine to reduce opioid use in patients with sickle cell disease experiencing severe pain crisis

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Centre Hospitalier Universitaire De Nantes

Study on Rilzabrutinib for Patients Aged 10-65 with Sickle Cell Disease

Investigational
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Rilzabrutinib
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study Comparing Clarithromycin and Azithromycin for Treating Mycobacterium Avium Complex Lung Infections in Adults

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Azithromycin
  • Sponsor:Centre Hospitalier Universitaire Amiens Picardie

Thyroid cancer+2

Recruiting

Study Comparing Two Treatment Strategies for Intermediate-Risk Thyroid Cancer Using Sodium Iodide (131I) in Patients with Post-Surgery Evaluation

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium iodide (131I)
  • Sponsor:Centre Francois Baclesse

Study on the Effects of Acetylsalicylic Acid and Atorvastatin in Patients with Castration-Resistant Prostate Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Institut Gustave Roussy

Study on the Effect of Rifampicin and Drug Combination for Patients with Staphylococcus aureus Bacteremia

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Universitair Medisch Centrum Utrecht

Leptospirosis

Not yet recruiting

Three‑Day versus Seven‑Day Antibiotic Treatment with doxycycline, amoxicillin and ceftriaxone in adults with mild leptospirosis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:CHU De Martinique

Pain management

Not yet recruiting

Comparing morphine and alfentanil for treating severe acute pain in adults before hospital admission

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Alfentanil hydrochloride
  • Sponsor:CHU De Martinique

Anaemia

Not recruiting

Study on the Effectiveness and Safety of Mitapivat for Patients with Sickle Cell Disease

Investigational
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Mitapivat
  • Sponsor:Agios Pharmaceuticals Inc.
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Inaxaplin
  • Sponsor:Vertex Pharmaceuticals Inc.

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Les Abymes

What the registry says about research in the country

01 Thyroid Cancer Research

Clinical investigations focusing on intermediate-risk differentiated thyroid cancer patients, evaluating different approaches to radioiodine treatment administration. The research aims to compare systematic treatment versus a guided decision-making process based on specific diagnostic markers.

  • Post-operative assessment protocols
  • Radioiodine treatment strategies
  • Treatment response monitoring

This study represents a significant advancement in personalizing thyroid cancer treatment approaches.

02 Hematological Disorders

Innovative research exploring treatment options for patients with sickle cell disease, specifically targeting anemia and pain crisis management. The study evaluates the effectiveness of new therapeutic compounds in improving patient outcomes.

  • Anemia management
  • Pain crisis prevention
  • Novel therapeutic approaches

This research aims to enhance the quality of life for individuals affected by sickle cell disease through targeted intervention strategies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.